S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Laser breakthrough could send stock soaring 2,467% (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Critical asset just had biggest fall on record (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Laser breakthrough could send stock soaring 2,467% (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Laser breakthrough could send stock soaring 2,467% (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Critical asset just had biggest fall on record (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Laser breakthrough could send stock soaring 2,467% (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Laser breakthrough could send stock soaring 2,467% (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Critical asset just had biggest fall on record (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Laser breakthrough could send stock soaring 2,467% (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Laser breakthrough could send stock soaring 2,467% (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
Critical asset just had biggest fall on record (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
Laser breakthrough could send stock soaring 2,467% (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Cellectar Biosciences (CLRB) News Today

$3.35
+0.08 (+2.45%)
(As of 02/22/2024 ET)
SourceHeadline
benzinga.com logoCellectar Biosciences Stock (NASDAQ:CLRB), Short Interest Report
benzinga.com - February 22 at 7:30 PM
money.usnews.com logoCellectar Biosciences Inc
money.usnews.com - February 15 at 3:11 PM
MarketBeat logoCellectar Biosciences (NASDAQ:CLRB) Share Price Passes Above 50 Day Moving Average of $3.16
americanbankingnews.com - February 14 at 4:56 AM
seekingalpha.com logoCellectar Biosciences: A Shoestring Opportunity You're About To Miss
seekingalpha.com - February 12 at 4:35 AM
finance.yahoo.com logoCellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
finance.yahoo.com - February 7 at 10:51 AM
finance.yahoo.com logoCellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million
finance.yahoo.com - January 25 at 10:20 AM
investing.com logoCellectar Biosciences Inc (CLRB)
investing.com - January 23 at 3:40 PM
msn.com logoCellectar stock climbs 8% on results for CNS malignancy therapy
msn.com - January 22 at 7:13 PM
finance.yahoo.com logoCellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient
finance.yahoo.com - January 22 at 8:25 AM
finance.yahoo.com logoCellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
finance.yahoo.com - January 16 at 7:45 AM
finance.yahoo.com logoCellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
finance.yahoo.com - January 12 at 7:39 AM
marketwatch.com logoCellectar Biosciences Shares Hit 52-Week High After Positive Iopofosine I Results
marketwatch.com - January 8 at 2:05 PM
msn.com logoWhy Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today?
msn.com - January 8 at 2:05 PM
marketwatch.com logoCellectar Biosciences' Iopofosine I Meets Primary Endpoint in Rare Blood Cancer Study
marketwatch.com - January 8 at 9:05 AM
reuters.com logoCellectar's blood cancer therapy succeeds in trial
reuters.com - January 8 at 9:05 AM
msn.com logoCellectar Biosciences gains on pivotal data for radiotherapy
msn.com - January 8 at 9:05 AM
msn.com logoWhy Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
msn.com - January 8 at 9:05 AM
finance.yahoo.com logoCellectar Biosciences Announces Positive Topline Data Achieving Primary Endpoint in Pivotal Clinical Study of Iopofosine I 131 in Waldenstrom’s Macroglobulinemia
finance.yahoo.com - January 8 at 9:05 AM
finance.yahoo.com logoCellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8, 2024
finance.yahoo.com - January 3 at 10:21 AM
finance.yahoo.com logoCellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation
finance.yahoo.com - December 19 at 9:24 AM
finance.yahoo.com logoCellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform
finance.yahoo.com - December 12 at 9:43 AM
finance.yahoo.com logoCellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit Europe
finance.yahoo.com - December 5 at 12:05 PM
finance.yahoo.com logoHere's Why We're A Bit Worried About Cellectar Biosciences' (NASDAQ:CLRB) Cash Burn Situation
finance.yahoo.com - November 23 at 5:35 PM
markets.businessinsider.com logoBuy Rating on Cellectar Biosciences: Promising Clinical Study, Fast Track Designation and Strong Financial Position
markets.businessinsider.com - November 4 at 10:57 PM
finance.yahoo.com logoCellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 4 at 12:44 PM
msn.com logoCellectar Biosciences Q3 2023 Earnings Preview
msn.com - November 2 at 8:01 AM
finance.yahoo.com logoCellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024
finance.yahoo.com - November 2 at 8:01 AM
finance.yahoo.com logoCellectar Biosciences Partners with Florida Cancer Specialists & Research Institute to Support the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting
finance.yahoo.com - October 25 at 8:56 AM
finance.yahoo.com logoCellectar Biosciences to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 2, 2023
finance.yahoo.com - October 24 at 8:56 AM
finance.yahoo.com logoCellectar Biosciences Expands Commercialization Leadership Team Ahead of Pivotal Data for Iopofosine I-131 in Waldenstrom's Macroglobulinemia
finance.yahoo.com - October 17 at 10:43 AM
seekingalpha.com logoCellectar Biosciences files to sell 34.5M shares for holders
seekingalpha.com - October 7 at 10:22 AM
marketwatch.com logoCellectar Biosciences Shares Rise 10% After Being Granted Four Patents
marketwatch.com - October 2 at 2:01 PM
finance.yahoo.com logoCellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants
finance.yahoo.com - October 2 at 8:58 AM
finance.yahoo.com logoCellectar Biosciences Receives European Medicines Agency Priority Medicines (PRIME) Designation for Iopofosine for Waldenstrom’s Macroglobulinemia
finance.yahoo.com - September 18 at 12:11 PM
benzinga.com logoNano-Cap Medical Technology Watchlist (ORHB, BBLG, CLRB, MOVE)
benzinga.com - September 18 at 7:11 AM
benzinga.com logoCellectar Biosciences Announces Closing of up to Approximately $103 Million Private Placement Financing
benzinga.com - September 11 at 6:53 PM
marketwatch.com logoCellectar Biosciences Shares Rise 18% After Private Placement Financing
marketwatch.com - September 5 at 4:27 PM
msn.com logoCellectar Biosciences announces up to ~$103M private placement financing
msn.com - September 5 at 4:27 PM
finance.yahoo.com logoCellectar Biosciences Announces up to Approximately $103 Million Private Placement Financing
finance.yahoo.com - September 5 at 4:27 PM
finanznachrichten.de logoCellectar Biosciences: Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
finanznachrichten.de - August 14 at 6:43 PM
finance.yahoo.com logoCellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
finance.yahoo.com - August 14 at 6:43 PM
finance.yahoo.com logoCellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting
finance.yahoo.com - June 28 at 11:27 AM
finance.yahoo.com logoCLRB - Cellectar Biosciences, Inc.
finance.yahoo.com - June 27 at 4:40 PM
finance.yahoo.com logoCellectar Provides a Research and Development Program Summary
finance.yahoo.com - June 12 at 6:05 PM
morningstar.com logoUPDATE — Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
morningstar.com - May 6 at 11:25 PM
seekingalpha.com logoCellectar Biosciences GAAP EPS of -$0.76
seekingalpha.com - May 6 at 11:25 PM
msn.com logoRecap: Cellectar Biosciences Q1 Earnings
msn.com - May 4 at 2:52 PM
finanznachrichten.de logoCellectar Biosciences: Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
finanznachrichten.de - May 4 at 9:51 AM
finance.yahoo.com logoCellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
finance.yahoo.com - May 4 at 9:51 AM
finance.yahoo.com logoUPDATE -- Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
finance.yahoo.com - May 4 at 9:51 AM
Get Cellectar Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLRB and its competitors with MarketBeat's FREE daily newsletter.



CLRB Media Mentions By Week

CLRB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLRB
News Sentiment

0.46

0.48

Average
Medical
News Sentiment

CLRB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLRB Articles
This Week

1

1

CLRB Articles
Average Week

Get Cellectar Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLRB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CLRB) was last updated on 2/23/2024 by MarketBeat.com Staff